23 August 2022: Original Paper
Management of Spontaneous Portosystemic Shunts in 231 Patients Who Underwent Living Donor Liver Transplantation: A Retrospective Study from a Single Center in Nagasaki, Japan
Takashi Hamada ABCDEF , Masaaki Hidaka ACDEF* , Akihiko Soyama ACDF , Takanobu Hara ADF , Hajime Imamura ADF , Hajime Matsushima ADF , Takayuki Tanaka ADF , Tomohiko Adachi ADF , Kengo Kanetaka DF , Susumu Eguchi ADFDOI: 10.12659/AOT.936371
Ann Transplant 2022; 27:e936371
Table 1 Patient characteristics (ligation group vs non-ligation group).
| Ligation (n=20) | Non-ligation (n=43) | P value | |
|---|---|---|---|
| Age, years | 58 (50–72) | 58 (33–68) | 0.73 |
| Sex, male | 12 (60.0) | 22 (48.9) | 0.59 |
| Etiology | |||
| HCV | 10 (50.0) | 19 (44.2) | |
| HBV | 3 (15.0) | 9 (20.9) | |
| Alcoholic cirrhosis | 4 (20.0) | 2 (4.7) | |
| PBC | 1 (5.0) | 4 (9.3) | |
| PSC | 0 (0) | 3 (7.0) | |
| Others | 2 (10.0) | 6 (14.0) | |
| HCC | 8 (40.0) | 21 (48.8) | 0.59 |
| Child-Pugh score | 11.5 (7–14) | 10 (7–14) | 0.49 |
| MELD score | 17.5 (10–31) | 16 (8–38) | 0.99 |
| Graft, left lobe | 10 (50.0) | 29 (67.4) | 0.27 |
| GW/SLV,% | 45.2 (25.6–63.6) | 38.1 (26.4–60.3) | 0.04 |
| Operative time, minutes | 740.5 (634–999) | 814 (503–1159) | 0.09 |
| Blood loss, g | 4931 (1620–18 000) | 5880 (1,120–18 400) | 0.66 |
| Splenectomy | 10 (50.0) | 27 (62.8) | 0.41 |
| Postoperative hospital stay (days) | 48.5 (22–220) | 50 (19–112) | 0.74 |
| Data are presented as n (%) or the median (range). HCV - hepatitis C virus; HBV - hepatitis B virus; PBC - primary biliary cirrhosis; PSC - primary sclerosing cholangitis; HCC: hepatocellular carcinoma; MELD - model for end-stage liver disease; GW - graft weight; SLV - standard liver volume. | |||